PROCESS FOR PRODUCING GALENIC COMPOSITIONS ENSURING OPTIMAL BIOLOGICAL ACCESSIBILITY OF 2-HYDROXY-5-METHYLLAUROPHENONEOXIME ACTIVE INGREDIENT

摘要

The drug form is particularly suitable for oral administration. The improved bioavailability is achieved by considerably improving the absorption of the active ingredient HMLO in the presence of bile acid. Bile acids which can be used are, for example, deoxy- or dehydrocholic acid or a mixture of the two in the form of their salts.